×

Marrone Bio Innovations and Informa to Host Webinar on Spotted Wing Drosophila Integrated Pest Management

DAVIS, Calif., June 5, 2015 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, and in association with Informa's Crops and Chemicals USA event, the global information specialist for the food and agricultural supply chain, today announced that they will host a free webinar on the topic of Spotted Wing Drosophila Integrated Pest Management (IPM) on June 10th at 11:00 AM ET.

The webinar will be led by Dr. Tim Johnson, Product Development Manager for Marrone Bio Innovations. Other presenters include:

  • Dr. Hannah Burrack, Associate Professor of Entomology and Extension Specialist, North Carolina State University
  • Dr. Cesar Rodriguez-Saona, Associate Extension Specialist in Entomology, Rutgers University
  • Dr. Richard Cowles, Agricultural Scientist, Connecticut Agricultural Experiment Station

"Spotted Wing Drosophila is an invasive pest that is causing major problems in fruit and berry crops and it is spreading globally," said MBI's Tim Johnson. "This webinar will provide a detailed summary of IPM management tactics to control this invasive pest and protect fruit crops in both conventional and organic production."

The webinar is available at no charge in association with Informa's Crops and Chemicals USA event and can be accessed via the following link: https://attendee.gotowebinar.com/register/6506055859268469250

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (Nasdaq:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

Portions of this press release may constitute "forward-looking statements," and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the "PSLRA"), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the "safe-harbor" protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding implementing our business strategy, expectations regarding our sales team and driving sales of our products. Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include adverse weather conditions and seasonality that may affect sales, failure of customers to adopt our products, the high level of competition in the market for pest management products, inability to maintain and further establish successful relationships with third-party distributors, the failure of our third-party distributors to sell to end users and uncertainty surrounding our compliance with our financial reporting obligations. Additional information that could lead to material changes in our performance is contained in our filings with the Securities and Exchange Commission.

CONTACT: Media Contact: Cory Ziskind ICR 646-277-1232 Cory.Ziskind@icrinc.com

Source:Marrone Bio Innovations